Kin Yip Leung
Directeur/Membre du Conseil chez NOVOCURE LIMITED
Fortune : 1 M $ au 30/06/2024
Profil
Kin Yip Leung is currently the Vice Chairman at NovoCure Ltd.
He previously served as an Independent Director at Curia Global, Inc. from 2010 to 2016.
He also held the position of Director at Delcath Systems, Inc. in 2014.
Additionally, he was a Director at NanoMed Pharmaceuticals, Inc. Mr. Leung served as an Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2016 to 2019.
Prior to that, he worked as a Principal at Bristol Myers Squibb Co. from 1990 to 1999.
He then served as EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. from 2003 to 2010.
Mr. Leung was also the Group Vice President-Global Prescription Business at Pharmacia Corp.
from 1999 to 2003.
He is a graduate of the University of Wisconsin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVOCURE LTD.
0,08% | 05/06/2024 | 83 192 ( 0,08% ) | 1 M $ | 30/06/2024 |
Postes actifs de Kin Yip Leung
| Sociétés | Poste | Début |
|---|---|---|
| NOVOCURE LIMITED | Directeur/Membre du Conseil | 05/08/2011 |
Anciens postes connus de Kin Yip Leung
| Sociétés | Poste | Fin |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Directeur/Membre du Conseil | 09/05/2019 |
| ALBANY MOLECULAR RESEARCH, INC. | Directeur/Membre du Conseil | 04/02/2016 |
| DELCATH SYSTEMS, INC. | Président | 15/09/2014 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2010 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/04/2003 |
Formation de Kin Yip Leung
| The University of Texas at Austin | Undergraduate Degree |
| University of Wisconsin | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Entreprise privées | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Commercial Services |
| C-Change | |
Curia Global, Inc.
 Curia Global, Inc. BiotechnologyHealth Technology Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
